PTCY-BASED HAPLOIDENTICAL TRANSPLANTATION, WITH REDUCED-DOSE MMF, 30 MG/KG, AND A CALCINEURIN INHIBITOR, COMPARED WITH ATG-BASED, 6 MG/KG, UNRELATED DONOR TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES LJ Arcuri; CO Ribeiro; IO Fernandes-Junior; SC Maradei; SP Lermontov; D Lerner;

DEMANDAS ODONTOLÓGICAS PRÉVIAS AO TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS LDB Alves; JF Tagliabue; JKP Queiroz; JSR Pereira; ACS Menezes; SP Lermontov; SCM Pereira; MCR Moreira; D Lerner; HS Antunes;

POSTTRANSPLANT CYCLOPHOSPHAMIDE OR ANTI-THYMOCYTE GLOBULIN FOR UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION LJ Arcuri; MN Kerbauy; GF Perini; AAF Ribeiro; FPdS Santos; N Hamerschlak; CO Ribeiro;